82
views
0
recommends
+1 Recommend
0 collections
    8
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Immune Enhancement of Skin Carcinogenesis by CD4 + T Cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In a transgenic model of multi-stage squamous carcinogenesis induced by human papillomavirus (HPV) oncogenes, infiltrating CD4 + T cells can be detected in both premalignant and malignant lesions. The lymph nodes that drain sites of epidermal neoplasia contain activated CD4 + T cells predominantly reactive toward Staphylococcal bacterial antigens. HPV16 mice deficient in CD4 + T cells were found to have delayed neoplastic progression and a lower incidence of tumors. This delay in carcinogenesis is marked by decreased infiltration of neutrophils, and reduced activity of matrix metalloproteinase-9, an important cofactor for tumor progression in this model. The data reveal an unexpected capability of CD4 T cells, whereby, proinflammatory CD4 + T cells, apparently responding to bacterial infection of dysplastic skin lesions, can inadvertently enhance neoplastic progression to invasive cancer.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Neurotransmitter synthesis and uptake by isolated sympathetic neurones in microcultures.

          Assays of isolated single sympathetic neurones show that their transmitter functions can be either adrenergic or cholinergic depending on growth conditions. The data suggest that the number of transmitters made by most mature individual neurones is restricted.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

            The matrix metalloproteinase MMP-9/gelatinase B is upregulated in angiogenic dysplasias and invasive cancers of the epidermis in a mouse model of multi-stage tumorigenesis elicited by HPV16 oncogenes. Transgenic mice lacking MMP-9 show reduced keratinocyte hyperproliferation at all neoplastic stages and a decreased incidence of invasive tumors. Yet those carcinomas that do arise in the absence of MMP-9 exhibit a greater loss of keratinocyte differentiation, indicative of a more aggressive and higher grade tumor. Notably, MMP-9 is predominantly expressed in neutrophils, macrophages, and mast cells, rather than in oncogene-positive neoplastic cells. Chimeric mice expressing MMP-9 only in cells of hematopoietic origin, produced by bone marrow transplantation, reconstitute the MMP-9-dependent contributions to squamous carcinogenesis. Thus, inflammatory cells can be coconspirators in carcinogenesis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Regulation of cutaneous malignancy by gammadelta T cells.

              The localization of gammadelta T cells within epithelia suggests that these cells may contribute to the down-regulation of epithelial malignancies. We report that mice lacking gammadelta cells are highly susceptible to multiple regimens of cutaneous carcinogenesis. After exposure to carcinogens, skin cells expressed Rae-1 and H60, major histocompatibility complex-related molecules structurally resembling human MICA. Each of these is a ligand for NKG2d, a receptor expressed by cytolytic T cells and natural killer (NK) cells. In vitro, skin-associated NKG2d+ gammadelta cells killed skin carcinoma cells by a mechanism that was sensitive to blocking NKG2d engagement. Thus, local T cells may use evolutionarily conserved proteins to negatively regulate malignancy.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                21 April 2003
                : 197
                : 8
                : 1017-1028
                Affiliations
                [1 ]Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
                [2 ]Division of Hematology/Oncology, Department of Medicine
                [3 ]Cancer Research Institute, Department of Pathology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143
                Author notes

                Address correspondence to Douglas Hanahan, Diabetes Center, 513 Parnassus Ave., HSW 1090, University of California, San Francisco, San Francisco, CA 94143-0534. Phone: 415-476-9209; Fax: 415-731-3612; E-mail: dh@ 123456biochem.ucsf.edu

                Article
                20021047
                10.1084/jem.20021047
                2193878
                12695493
                234d04a4-9439-4a73-b5ec-00b02539ceae
                Copyright © 2003, The Rockefeller University Press
                History
                : 25 June 2002
                : 21 February 2003
                : 28 February 2003
                Categories
                Article

                Medicine
                inflammation,mice,lymphocyte,cancer,transgenic
                Medicine
                inflammation, mice, lymphocyte, cancer, transgenic

                Comments

                Comment on this article